Paper31233332
Aptamer-Functionalized Bioscaffold Enhances Cartilage Repair by Improving Stem Cell Recruitment in Osteochondral Defects of Rabbit Knees.
Wang X and 6 others. Am J Sports Med, 2019. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Aptamer-Functionalized Bioscaffold Enhances Cartilage Repair by Improving Stem Cell Recruitment in Osteochondral Defects of Rabbit Knees. Papers, record 31233332. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31233332
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Aptamer-Functionalized Bioscaffold Enhances Cartilage Repair by Improving Stem Cell Recruitment in Osteochondral Defects of Rabbit Knees.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aptamers, Nucleotide | Major topic |
| Cartilage, Articular | Major topic |
| Knee Injuries | Major topic |
| Mesenchymal Stem Cell Transplantation | Major topic |
| Tissue Scaffolds | Major topic |
| Animals | |
| Biocompatible Materials | |
| Fibroins | |
| Hyaluronic Acid | |
| Hydrogels | |
| Mesenchymal Stem Cells | |
| Rabbits | |
| Tissue Engineering |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42789016 | Next-Generation Bone Marrow Cell Therapies for Cardiac Repair: Integrating Gene Therapy and Bioengineering to Enhance Therapeutic Potency. | J Cardiovasc Transl Res | 2026 | https://conductscience.org/library/papers/42789016 | PubMed |
| 42461853 | Aptamer-functionalized stiff hydrogel for enhanced BMSC enrichment and osteogenesis. | PLoS One | 2026 | https://conductscience.org/library/papers/42461853 | PubMed |
| 41797965 | Pathology-guided design of injectable hydrogels for precision therapy and cartilage regeneration in osteoarthritis. | Regen Biomater | 2026 | https://conductscience.org/library/papers/41797965 | PubMed |
| 41560823 | Functional nucleic acid Hydrogels: Paving the way for Next-generation bone and cartilage regeneration. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41560823 | PubMed |
| 40211705 | Osteochondral tissue engineering‑based subchondral bone plate repair (Review). | Mol Med Rep | 2025 | https://conductscience.org/library/papers/40211705 | PubMed |
| 39744693 | Silk fibroin-based hydrogels for cartilage organoids in osteoarthritis treatment. | Theranostics | 2025 | https://conductscience.org/library/papers/39744693 | PubMed |
| 38803845 | Designing molecules: directing stem cell differentiation. | Front Bioeng Biotechnol | 2024 | https://conductscience.org/library/papers/38803845 | PubMed |
| 38333081 | Protecting the regenerative environment: selecting the optimal delivery vehicle for cartilage repair-a narrative review. | Front Bioeng Biotechnol | 2024 | https://conductscience.org/library/papers/38333081 | PubMed |
| 38024846 | Aptamer-functionalized hydrogels promote bone healing by selectively recruiting endogenous bone marrow mesenchymal stem cells. | Mater Today Bio | 2023 | https://conductscience.org/library/papers/38024846 | PubMed |
| 37711133 | Comparative Efficacy of Endogenous Stem Cells Recruiting Hydrogels and Stem Cell-loaded Hydrogels in Knee Cartilage Regeneration: A Meta- analysis. | Curr Stem Cell Res Ther | 2024 | https://conductscience.org/library/papers/37711133 | PubMed |
| 37304336 | Engineered biochemical cues of regenerative biomaterials to enhance endogenous stem/progenitor cells (ESPCs)-mediated articular cartilage repair. | Bioact Mater | 2023 | https://conductscience.org/library/papers/37304336 | PubMed |
| 37265990 | Aptamer-enriched scaffolds for tissue regeneration: a systematic review of the literature. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/37265990 | PubMed |
| 37017917 | Advantages of Material Biofunctionalization Using Nucleic Acid Aptamers in Tissue Engineering and Regenerative Medicine. | Mol Biotechnol | 2023 | https://conductscience.org/library/papers/37017917 | PubMed |
| 36768328 | Targeting Agents in Biomaterial-Mediated Bone Regeneration. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768328 | PubMed |
| 36591965 | Aptamer Technology and Its Applications in Bone Diseases. | Cell Transplant | 2023 | https://conductscience.org/library/papers/36591965 | PubMed |
| 36568290 | Etanercept embedded silk fibroin/pullulan hydrogel enhance cartilage repair in bone marrow stimulation. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36568290 | PubMed |
| 36420054 | Designing functional hyaluronic acid-based hydrogels for cartilage tissue engineering. | Mater Today Bio | 2022 | https://conductscience.org/library/papers/36420054 | PubMed |
| 36176622 | Integrated bioactive scaffold with aptamer-targeted stem cell recruitment and growth factor-induced pro-differentiation effects for anisotropic meniscal regeneration. | Bioeng Transl Med | 2022 | https://conductscience.org/library/papers/36176622 | PubMed |
| 36105606 | Application of aptamers in regenerative medicine. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36105606 | PubMed |
| 35836802 | Silk fibroin-based biomaterials for cartilage/osteochondral repair. | Theranostics | 2022 | https://conductscience.org/library/papers/35836802 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31233332
GET https://conductscience.org/api/papers/v1/31233332/cited_by?page=2